VoxDev Development Economics

← VoxDev Development Economics7 oct · 34 min

S7 Ep50: Evidence-based policy: Why one good trial isn't enough

S7 Ep50: Evidence-based policy: Why one good trial isn't enough7 oct34 min

Medicine has run rigorous clinical trials since the 1940s. Development economists borrowed the structure of the trials during the credibility revolution. Chris Cotton (Queen's University) argues that they misunderstood an important part of this revolution. One successful study is not a mature evidence base, and policies built on too little evidence tend to disappoint at scale.

His answer is a framework of Policy Evidence Readiness Levels, or PERLs, just published in Science. PERLs 1 through 4 categorise the weight of evidence behind an intervention, and are inspired by the scale NASA uses to judge whether a technology is ready for a space mission. He tells Tim Phillips which development programmes have already climbed to the top rung, which were implemented at scale on too little evidence (and what happened when they were), and why his framework, by his own admission, is still a modest PERL level 1.

The research behind this episode

Cotton, Christopher. 2026. "Rigor Is Not Readiness: The PERL Framework for Evidence-Based Policy." Science 393 (6810): 463-465.

To cite this episode

Phillips, Tim, and Christopher Cotton. 2026. "Evidence-based policy: Why one good trial isn't enough." VoxDev Talks (podcast).

About the guest

Christopher Cotton is Professor of Economics at Queen's University in Kingston, Ontario, where he holds the Jarislowsky-Deutsch Chair in Economic and Financial Policy and directs the John Deutsch Institute for the Study of Economic Policy. He is cross-appointed to the School of Policy Studies and the Department of Medicine. His research spans evidence-based policy, the economics of science, education and public health, and how organisations use expertise when they make decisions. He is a co-owner of and research adviser at Limestone Analytics, a policy advisory firm, and has advised on impact evaluation and evidence-based policy for the UK and US governments, the World Health Organization, and others.

Research cited in this episode

Evidence-based medicine. The movement that took hold in the 1990s, decades after the clinical trial became standard. Its classic statement is Sackett, David L., William M. C. Rosenberg, J. A. Muir Gray, R. Brian Haynes, and W. Scott Richardson. 1996. "Evidence Based Medicine: What It Is and What It Isn't." BMJ 312 (7023): 71-72. It set out how clinicians should combine the best research evidence with clinical judgement. Cotton's point is that medicine's evidence hierarchy puts systematic reviews above any sin